With the growth of online technology and mobile innovations, health information has never been more accessible. Given the constraints of working in a tightly regulated environment, life sciences companies (pharma, biotech and medical devices) have moved slowly to adopt Health 2.0, treating it as a minor component of their commercial strategies and marketing plans. In contrast, patients, physicians and other key health care stakeholders have readily adopted Health 2.0. This ultimately decreases the level of control that life sciences companies have over the way their customers obtain product information and marketing messages.
The report is available to download from the Capgemini website (pre-registration is required).